Evidence map›Paper›PMID 21987573›Full record

ArticleThe Journal of biological chemistry2011

Fibroblast growth factor 2 stimulation of osteoblast differentiation and bone formation is mediated by modulation of the Wnt signaling pathway.

Yurong Fei, Liping Xiao, Thomas Doetschman, Douglas J Coffin, Marja M Hurley

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 114 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Identification of a Force-Induced Sox9Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  5. Review
  6. Role of FGF2 in promoting osteogenic differentiation for craniofacial bone regeneration.Regenerative engineering and translational medicine · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Modeling of skeletal development and diseases using human pluripotent stem cells.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Review
  12. Review
  13. Article
  14. Bone-muscle crosstalk under physiological and pathological conditions.Cellular and molecular life sciences : CMLS · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Yurong FeiUniversity of Connecticut Health Center, Farmington, Connecticut 06030, USA.
Liping Xiao
Thomas Doetschman
Douglas J Coffin
Marja M Hurley
UConn Health · USUniversity of Arizona · USUniversity of Montana · US

Funding

Action of Anbolic Factors on Bone Formation in MiceR01AG021189 · NIA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HURLEY, MARJA MARIE · 2004 to 2013
$2.5M
NIA NIH HHS AG021189NIA NIH HHS R01 AG021189
6 · The paper itself

Abstract

Fibroblast growth factor 2 (FGF2) positively modulates osteoblast differentiation and bone formation. However, the mechanism(s) is not fully understood. Because the Wnt canonical pathway is important for bone homeostasis, this study focuses on modulation of Wnt/β-catenin signaling using Fgf2(-/-) mice (FGF2 all isoforms ablated), both in the absence of endogenous FGF2 and in the presence of exogenous FGF2. This study demonstrates a role of endogenous FGF2 in bone formation through Wnt signaling. Specifically, mRNA expression for the canonical Wnt genes Wnt10b, Lrp6, and β-catenin was decreased significantly in Fgf2(-/-) bone marrow stromal cells during osteoblast differentiation. In addition, a marked reduction of Wnt10b and β-catenin protein expression was observed in Fgf2(-/-) mice. Furthermore, Fgf2(-/-) osteoblasts displayed marked reduction of inactive phosphorylated glycogen synthase kinase-3β, a negative regulator of Wnt/β-catenin pathway as well as a significant decrease of Dkk2 mRNA, which plays a role in terminal osteoblast differentiation. Addition of exogenous FGF2 promoted β-catenin nuclear accumulation and further partially rescued decreased mineralization in Fgf2(-/-) bone marrow stromal cell cultures. Collectively, our findings suggest that FGF2 stimulation of osteoblast differentiation and bone formation is mediated in part by modulating the Wnt pathway.

Indexed as

Cell DifferentiationOsteogenesisWnt Signaling PathwayActive Transport, Cell NucleusAnimalsbeta CateninCell NucleusFemaleFibroblast Growth Factor 2Gene Expression RegulationGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaIntercellular Signaling Peptides and ProteinsLow Density Lipoprotein Receptor-Related Protein-6MaleMicebeta CateninDkk2 protein, mouseFibroblast Growth Factor 2Glycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGsk3b protein, mouseIntercellular Signaling Peptides and ProteinsLow Density Lipoprotein Receptor-Related Protein-6Lrp6 protein, mouseRNA, MessengerWnt10b protein, mouseWnt Proteins

Identifiers

PMID21987573
PMCPMC3220493
OpenAlexW1978421713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.